Carla O’Connor, Deciem’s director of clinical research, will explore how clinical validation and internal standards for substantiated results shapes its innovation pipeline. O’Connor will explore clinical pillars, highlighting how novel method development and the integration of internal and external studies support robust, final claims and marketing at the skin care company, which is part of The Estée Lauder Companies. She will speak at 10:30 am on April 15 in the Marketing Trends Theatre (Hall 7).

Her presentation, “Results with Integrity: The Deciem Model for Evidence-Based Skincare,” will connect internal ingredient discovery with formulation science, emphasizing mechanisms of action through a focused case study. This presentation will reinforce the company’s commitment to leading with science, transparency, and integrity  and offer a glimpse into how these principles will guide its next chapter of evidence-based innovations.